Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Dosing begins in NIH-funded phase II proof-of-concept study of ANS-6637

Oct. 18, 2019

AstraZeneca initiates first-in-human study of AZD-4041 in healthy volunteers

Oct. 15, 2019

Humanetics' development of radioprotectant BIO-301 supported by DoD cooperative research agreement

Oct. 2, 2019

NIDA grant supports Kinoxis' development of KNX-100 for opioid withdrawal

Oct. 1, 2019

Emergent BioSolutions, Indivior win NIH grants to study drugs for opioid use disorder

Sep. 30, 2019

NIDA award to support Ensysce's development of opioid use disorder product

Sep. 27, 2019

Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction

Sep. 18, 2019

Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse

Sep. 10, 2019

A novel preclinical model of cocaine and alcohol coabuse

Sep. 6, 2019

Discovery of a selective OX1 receptor antagonist for substance abuse and dependency

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...